MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer

被引：0
|
作者：
Yamasaki, Juntaro [1 ]
Otsuki, Yuji [1 ]
Masuda, Kenta [2 ]
Saya, Hideyuki [3 ]
Nagano, Osamu [1 ]
机构：
[1] Keio Univ, Sch Med, Div Gene Regulat, IAMR, Keio, Japan
[2] Keio Univ, Dept Obstet Gynecol, Sch Med, Keio, Japan
[3] Fujita Hlth Univ, Div Gene Reg, Fujita Canc Ctr, Toyoake, Aichi, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1140
引用
收藏
页码：377 / 377
页数：1
相关论文
共 50 条
  • [1] MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer
    Yamasaki, Juntaro
    Hirata, Yuki
    Otsuki, Yuji
    Suina, Kentaro
    Saito, Yoshiyuki
    Masuda, Kenta
    Okazaki, Shogo
    Ishimoto, Takatsugu
    Saya, Hideyuki
    Nagano, Osamu
    CANCER SCIENCE, 2022, 113 (03) : 916 - 925
  • [2] MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer
    Yamasaki, Juntaro
    Otsuki, Yuji
    Masuda, Kenta
    Saya, Hideyuki
    Nagano, Osamu
    CANCER SCIENCE, 2023, 114 : 296 - 296
  • [3] Microenvironment targets in KRAS-mutated metastatic colorectal cancer
    Marchio, Serena
    Bartolini, Alice
    Cardaci, Sabrina
    Soster, Marco
    Corti, Giorgio
    Lamba, Simona
    Bussolino, Federico
    Cora', Davide
    Nicolantonio, Federica D.
    CANCER RESEARCH, 2014, 74 (19)
  • [4] Polo-like Kinase 1 Inhibition in KRAS-Mutated Metastatic Colorectal Cancer
    Stebbing, Justin
    Bullock, Andrea J.
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2005 - 2007
  • [5] Advanced therapies on BRAF-mutated and KRAS-mutated metastatic colorectal cancer
    LI Zi-nan
    YU Li-feng
    WANG Jia-qi
    NIU Yan-xin
    WANG Xin-yu
    ZHAO Lin
    中国药理学与毒理学杂志, 2019, (10) : 883 - 883
  • [6] Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in KRAS-mutated colorectal cancer
    Ghosh, Susmita
    Fan, Fan
    Powell, Reid
    Park, Yong Sung
    Stephan, Clifford
    Kopetz, E. Scott
    Ellis, Lee M.
    Bhattacharya, Rajat
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [7] Sotorasib in KRAS-Mutated Colorectal Cancer
    Fojo, Tito
    Fakih, Marwan G.
    Chao, Joseph
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (02): : 186 - 187
  • [8] MYC inhibition by Omomyc as a therapeutic strategy for (KRAS-mutated) colorectal cancer
    Kaur, J.
    Martinez-Martin, S.
    Foradada, L.
    Lopez-Estevez, S.
    Serrano, E.
    Martin-Fernandez, G.
    Thabussot, H.
    Cano, V. Castillo
    Casacuberta-Serra, S.
    Zacarias-Fluck, M. F.
    Grueso, J.
    Beaulieu, M. E.
    Whitfield, J. R.
    Soucek, L.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S24 - S24
  • [9] Dual inhibition of MEK and p38 impairs tumor growth in KRAS-mutated non-small cell lung cancer
    Sunaga, Noriaki
    Miura, Yosuke
    Tsukagoshi, Yusuke
    Kasahara, Norimitsu
    Masuda, Tomomi
    Sakurai, Reiko
    Kaira, Kyoichi
    Hisada, Takeshi
    ONCOLOGY LETTERS, 2019, 17 (03) : 3569 - 3575
  • [10] MicroRNA signature associated with KRAS-mutated colorectal cancer
    Andreoiu, O-M
    Dobre, M.
    Pirvu, I-R
    Vasilescu, F.
    Herlea, V.
    Becheanu, G.
    VIRCHOWS ARCHIV, 2017, 471 : S161 - S162
12345